Graeme M. Robertson

Graeme Robertson is the Vice President of Therapeutic Research at Siena Biotech S.p.A. A company focussing on drug discovery targets in the areas of neurodegeneration and brain cancer. He is responsible for 4 units covering Medicinal Chemistry 1, Medicinal Chemistry 2, Drug Design and Information Technology, and Drug Profiling.
Graeme has detailed knowledge of the challenges of drug design gathered from more than 18 years experience in drug discovery. He has worked in several target classes and multiple disease areas, latterly concentrating on the exploratory phases and the introduction of novel methodologies for lead identification.
Prior to joining Siena Biotech, Graeme worked at GlaxoSmithKline where he held a variety of positions culminating in co-chair of the ion channel target class, in which he was responsible for development of ion channels as a drug target class and the introduction and leading of chemistry into this exciting area.
Graeme obtained his Ph.D. working with Prof. Pattenden at Nottingham University, UK and was a post-doctoral scientist with Prof. Overman at UC Irvine. He has published 25 scientific papers as well as numerous review articles.